Prognostic significance of p21waf1, cyclin D1 and retinoblastoma expression detected by immunohistochemistry in non-small cell lung cancer

被引:0
|
作者
Saitoh, G
Sugio, K
Ishida, T
Sugimachi, K
机构
[1] Atom Bomb Survivors Hosp, Naka Ku, Hiroshima 7308619, Japan
[2] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Higashi Ku, Fukuoka 8128582, Japan
关键词
p21(waf1); cyclin D1; retinoblastoma; immunohistochemistry; non-small cell lung cancer;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
p21(waf1) is a downstream effector of p53, and mediates growth arrest by inhibiting the action of G1 cyclin-dependent kinases. Cyclin D1 is a cell-cycle regulator essential for G1 phases progression and a candidate proto-oncogene implicated in the pathogenesis of several human tumor types. Cyclin D1 overexpression and the absence of retinoblastoma (Rb) protein have been frequently seen in various types of cancer, including lung cancer. The aim of this study was to clarify the relationship between the expressions of p21(waf1), cyclin D1, and Rb protein, and to investigate the correlation between these protein expressions and the clinical features of the patients, and their prognoses. We immunohistochemically examined 92 samples of resected non-small cell lung cancer for p21(waf1) cyclin D1, and Rb expression. Of the 92 specimens examined, 43 cases (46.7%) showed p21(waf1) expression, 23 cases (25.0%) showed cyclin D1 overexpression, and 61 cases (66.3%) showed Rb expression. No correlation was observed between the expressions of p21(waf1), cyclin D1, and Rb. There was no association of p21(waf1) and cyclin D1 immunoreactivity with gender, disease stage, or histological types of the tumor. Regarding the prognosis in 79 cases with complete resection, no statistical differences were observed according to the degree of expression of these three factors. However, when unfavorable prognostic factors were considered to be the positive expression of p21(waf1), positive of cyclin D1, and negative of Rb, the 5-year disease-free survival rate in the group with 2 or 3 unfavorable prognostic factors was 21.1%, which was statistically poorer than the 45.4% in the group with 0 or 1 unfavorable prognostic factor (p=0.0138). We conclude that examination of the expression of cell cycle regulators, such as p21(waf1), cyclin D1, and Rb, is useful as a prognostic indicator, when these proteins' expression is analyzed in combination.
引用
收藏
页码:737 / 743
页数:7
相关论文
共 50 条
  • [1] Absence of prognostic significance of p21WAF1/CIP1 protein expression in non-small cell lung cancer
    Dworakowska, D
    Jassem, E
    Jassem, J
    Boltze, C
    Wiedorn, KH
    Dworakowski, R
    Skokowski, J
    Jaskiewicz, K
    Czestochowska, E
    ACTA ONCOLOGICA, 2005, 44 (01) : 75 - 79
  • [2] The clinical significance of p21WAF1/CIP1 protein expression in non-small cell lung cancer
    Dworakowska, Dorota
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2006, 10 (01): : 24 - 27
  • [3] Prognostic significance of cyclin D1 and retinoblastoma expression in combination with p53 abnormalities in primary, resected non-small cell lung cancers
    Nishio, M
    Koshikawa, T
    Yatabe, Y
    Kuroishi, T
    Suyama, M
    Nagatake, M
    Sugiura, T
    Ariyoshi, Y
    Mitsudomi, T
    Takahashi, T
    Takahashi, T
    CLINICAL CANCER RESEARCH, 1997, 3 (07) : 1051 - 1058
  • [4] Cyclin D1 and retinoblastoma susceptibility gene alterations in non-small cell lung cancer
    Marchetti, A
    Doglioni, C
    Barbareschi, M
    Buttitta, F
    Pellegrini, S
    Gaeta, P
    La Rocca, R
    Merlo, G
    Chella, A
    Angeletti, CA
    Dalla Palma, P
    Bevilacqua, G
    INTERNATIONAL JOURNAL OF CANCER, 1998, 75 (02) : 187 - 192
  • [5] Expression and prognostic significance of cyclin B1 and cyclin A in non-small cell lung cancer
    Cooper, Wendy A.
    Kohonen-Corish, Maija R. J.
    McCaughan, Brian
    Kennedy, Catherine
    Sutherland, Robert L.
    Lee, Cheok Soon
    HISTOPATHOLOGY, 2009, 55 (01) : 28 - 36
  • [6] Apoptotic index in correlation with PCNA, p53, pRb, mdm2, p21WAF1/CIP1 and cyclin D1 expression in non-small cell lung cancer (NSCLC)
    Dworakowska, D.
    Karmolinski, A.
    Lapinski, M.
    Tomaszewski, D.
    Skokowski, J.
    Yla-Herttuala, S.
    Jaskiewicz, K.
    Jassem, E.
    Jassem, J.
    Czestochowska, E.
    Sworczak, K.
    LUNG CANCER, 2006, 52 : S21 - S21
  • [7] Cyclin D1, p53 and p21(waf1/cip1) expression predict survival in non-small cell lung cancer (NSCLC).
    Burke, L
    Freedman, A
    ElDeiry, W
    Bennett, W
    Guinee, D
    Rush, W
    Przygodzki, R
    Jones, R
    Borkowski, A
    Caporaso, N
    Fleming, MV
    Travis, W
    Colby, T
    Trastek, V
    Pairolero, P
    Tazelaar, H
    Midthun, D
    Liotta, L
    Vogelstein, B
    Harris, C
    LABORATORY INVESTIGATION, 1997, 76 (01) : 946 - 946
  • [8] Expression and prognostic relevance of STAT3 and cyclin D1 in non-small cell lung cancer
    Ai, Ting
    Wang, Zhouquan
    Zhang, Mingxin
    Zhang, Lingmin
    Wang, Ning
    Li, Weiwei
    Song, Liping
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2012, 27 (02): : E132 - E138
  • [9] Expression of cyclin E and cyclin D1 in non-small cell lung cancers
    Yamanouchi, H
    Furihata, M
    Fujita, J
    Murakami, H
    Yoshinouchi, T
    Takahara, J
    Ohtsuki, Y
    LUNG CANCER, 2001, 31 (01) : 3 - 8
  • [10] Evaluation of p21WAF1/CIP1 and cyclin D1 expression in the progression of superficial bladder cancer
    Liukkonen, T
    Lipponen, P
    Raitanen, M
    Kaasinen, E
    Ala-Opas, M
    Rajala, P
    Kosma, VM
    UROLOGICAL RESEARCH, 2000, 28 (05): : 285 - 292